ACHV

Achieve Life Sciences (ACHV)

About Achieve Life Sciences (ACHV)

Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada.

Details

Daily high

$3.74

Daily low

$3.30

Price at open

$3.65

52 Week High

$6.02

52 Week Low

$1.84

Market cap

215.6M

Dividend yield

0.00%

Volume

1.1M

Avg. volume

371,339

P/E ratio

-2.94

Achieve Life Sciences News